ABIONYX PHARMA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.146 EUR | -0.35% |
|
-1.72% | -36.40% |
| 06-14 | Abionyx: positive response from FDA, share price rises | CF |
| 06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
MarketScreener Editorial Features
Search
 | Global markets live: Tesla, McDonald's, Western Digital, Bed Bath & Beyond, Holcim... | April 03, 2023 at 10:53 am |
 | Global markets live: Airbus, Manchester United, EA, Credit Suisse, Warner... | March 30, 2023 at 11:09 am |
 | Global markets live: Airbus, JPMorgan Chase, Facebook, EasyJet, LVMH... | October 12, 2021 at 11:07 am |
 | Global markets live: Pirelli, Nintendo, Novavax, Amazon, HelloFresh | August 06, 2021 at 11:20 am |
 | Global markets live: Apple, Nvidia, Biogen, Fastly, Tilray... | June 08, 2021 at 10:20 am |
 | Global markets live: Square, Adidas, Peloton Interactive... | May 07, 2021 at 09:55 am |
No results for this search
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- News ABIONYX Pharma
- MarketScreener Editorial Features
